New oral contraceptive

    Parke-Davis will soon introduce a new oral contraceptive...the 21-day Estrostep, and the 28-day Estrostep FE.

    Estrostep is a "triphasic" pill with increasing doses of ESTROGEN...and a fixed dose of progestin.

    It provides 20 mcg of ethinyl estradiol for 5 days...30 mcg for 7 days...then 35 mcg for the last 9 days.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote